Insulin Pumps Market Size, Share | Industry Report by 2025

report image

Insulin Pumps Market to 2025 - Global Analysis and Forecasts By Type, (Tethered Pumps, and Untethered Pumps); Product (Pumps, and Accessories); Application (Type I Diabetes and Type II Diabetes and Geography

Publication Month: Aug 2018 | Report Code: TIPHE100001290 | No. of Pages: 154 | Category: Medical Device | Status: Published

The insulin pumps market accounted to US$ 3,822.4 Mn in 2017 and is expected to grow at a CAGR of 10.5% during the forecast period 2018 – 2025, to account to US$ 8,264.0 Mn by 2025.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American Insulin Pumps market is driven by the factors such as, rising geriatric population and increasing prevalence of diabetes in the region.

Lucrative Regional Markets

Get more information on this report :


Market Insights

Rapid Growth in the Geriatric Population

Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the globe. These population is growing exponentially worldwide. According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050.

Increasing Technological Advancement in Insulin Pumps

The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and Insulin Pumps. For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. In addition, in July 2018, Abbott announced to have a FDA approval for the FreeStyle Libre 14 day Flash Glucose Monitoring system that allows people with diabetes to wear the sensor up to 14 days with high accuracy. These advancements are expected to offer increasing demand for the products, hence providing better share to the market players.

Type Insights

The global insulin pumps market by type was led by tube pumps segment. In 2017, the pumps segment held a largest market share of 85.7% of the insulin pumps market, by type. The segment is also expected to dominate the market in 2025, since pump helps in delivering precise amount of insulin to the body than any other insulin delivery devices.

Product Insights

The global insulin pumps market by product was led by pumps segment. In 2017, the pumps segment held a largest market share of 76.8% of the insulin pumps market, by product. The segment is also expected to dominate the market in 2025, since they offer are used in the diabetes management for the administering of continues fast acting insulin in the body.

Application Insights

The insulin pumps market by application was segmented into type I diabetes and type II diabetes. The type I diabetes segment held the largest share of the market, by application. The segment is also likely to dominate during the forecast period, due to increase in the cases of type I diabetes among individuals, mostly in the developed nations.

Insulin Pumps Market, by Type

Get more information on this report :


Strategic Insights

Report Coverage - Insulin Pumps Market
Report CoverageDetails
Market Size Value inUS$ 3,822.4 Million in 2017
Market Size Value byUS$ 8,264.0 Million by 2025
Growth rateCAGR of 10.5% from 2018-2025
Forecast Period2018-2025
Base Year2018
No. of Pages154
No. of Tables81
No. of Charts & Figures64
Historical data availableYes
Segments coveredType, ; Product ; Application (Type I Diabetes and Type II Diabetes and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product approvals and partnerships & collaborations were observed as the most adopted strategy in global insulin pumps industry. Few of the product approvals and partnerships & collaborations made by the players in the market are listed below:

2018:In July, 2018, Roche gets CE Mark for its Accu-Chek Solo micropump system. The company plans to start with the pilot execution phase for innovative insulin delivery system in Switzerland, Poland, Austria, and the UK.
2018:In June, 2018, Insulet partnered with the European Region of the International Diabetes Federation (IDF Europe) to work together on regional advocacy activities.

INSULIN PUMPS – MARKET SEGMENTATION

By Product

  • Pumps
  • Accessories

By Type

  • Tube Pumps
  • Patch Pumps

By Application

  • Type I Diabetes
  • Type II Diabetes

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • UK
  • Asia Pacific (APAC)

    • China
    • India
    • Japan
  • Middle East & Africa (MEA)

    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)

    • Brazil

Company Profiles

  • Insulet Corporation
  • Medtronic
  • Tandem Diabetes Care, Inc
  • Debiotech S.A
  • CELLNOVO
  • SOOIL Developments Co., Ltd
  • MicroPort Scientific Corporation
  • Valeritas Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ypsomed AG

Frequently Asked Questions

The insulin pumps market size was calculable at US$ 3,822.4 Million in 2017 and is predicted to achieve at US$ 8,264.0 Million by 2025.
Globally, the insulin pump market is predicted to grow at a compound annual rate of growth of 10.5% throughout the forecast amount.
North America is that the largest geographic market and it's expected to be the biggest revenue generator throughout the forecast amount.
2018 is considered as base year for insulin pumps market report.
Some key players in operation within the insulin pump market include Insulet Corporation, Medtronic, Tandem Diabetes Care, Inc, Debiotech S.A, CELLNOVO, SOOIL Developments Co., Ltd, MicroPort Scientific Corporation, Valeritas Inc., F. Hoffmann-La Roche Ltd., Ypsomed AG.
Product approvals and partnerships & collaborations were determined as the most adopted strategy in insulin pumps industry, globally.

The List of Companies - Insulin Pumps Market

  1. Insulet Corporation
  2. Medtronic
  3. Tandem Diabetes Care, Inc
  4. Debiotech S.A
  5. CELLNOVO
  6. SOOIL Developments Co., Ltd
  7. MicroPort Scientific Corporation
  8. Valeritas Inc.
  9. F. Hoffmann-La Roche Ltd.
  10. Ypsomed AG
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the insulin pumps market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global insulin pumps market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPHE100001290
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550 $3000
  • $6550 $4000
  • $8550 $5000

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount